Healthcare (Women's Health)

introduced · Texas · House Aug 20, 2025

HB 271: Relating to the composition of the Texas Maternal Mortality and Morbidity Review Committee.

HB 271 amends the composition of Texas' Maternal Mortality and Morbidity Review Committee, increasing its membership from 23 to 25 members. The bill adds two new physician specialties (critical care and emergency care), two doulas with specific urban/rural representation requirements (one must specialize in end-of-life care), and a representative from a managed care organization. It also specifies that community members must include one urban and one rural representative, and requires at least one maternal fetal medicine specialist among obstetric physicians. The committee, which analyzes pregnancy-related deaths to improve maternal health outcomes, will now include these additional expertise areas to enhance its review capacity.

Topics ✓ HealthcareSupports HealthcareAdds health specialists (critical care, emergency care) and doulas to maternal review committee, enhancing oversight of maternal mortality/morbidity to improve healthcare outcomes.85% confidence

Sub-Topics Women's Health

Track

signed · Texas · House Sep 17, 2025

HB 7: Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.

HB 7, the Woman and Child Protection Act, prohibits the manufacture and provision of abortion-inducing drugs in Texas while limiting legal actions against certain local providers. It creates new legal protections for Texas-based hospitals, health facilities, and providers who practice exclusively within the state, shielding them from civil lawsuits under this law. The bill also restricts courts outside Texas from enforcing judgments related to abortion drugs and allows private citizens to file lawsuits ("qui tam actions") against violators. It directly affects drug manufacturers, pharmacies, and healthcare entities offering abortion-inducing drugs, but excludes Texas hospitals, state facilities, and in-state-only providers from liability. The law takes effect immediately upon the governor’s signature.

Topics ✗ HealthcareOpposes HealthcareProhibits abortion-inducing drugs, restricting access to reproductive healthcare services and limiting patient options within healthcare coverage.95% confidence

Sub-Topics Women's Health

in committee · Texas · Senate Aug 18, 2025

SB 7: Relating to abortion, including civil liability for the manufacture and provision of abortion-inducing drugs, exemptions from the Texas Citizens Participation Act and Religious Freedom Restoration Act, authorizing civil and qui tam actions, amendments to the fee-shifting statute governing abortion litigation, immunity defenses and limits on state-court jurisdiction and relief, the parens patriae standing of the attorney general, and the jurisdiction of the Fifteenth Court of Appeals; providing for severability.

SB 7 creates civil liability for manufacturers and providers of abortion-inducing drugs, with key exemptions for medical emergencies, ectopic pregnancies, and spontaneous miscarriages. It allows private citizens to file lawsuits (qui tam actions) seeking damages against those supplying such drugs, while modifying fee-shifting rules in abortion litigation. The bill also grants the Texas attorney general expanded authority to pursue cases under the "Woman and Child Protection Act" and alters jurisdiction for related court cases. It does not restrict medical procedures covered by the specified exemptions.

Topics ✗ HealthcareOpposes HealthcareSB 7 restricts abortion access by imposing civil liability on providers of abortion drugs and enabling private lawsuits, directly limiting a healthcare service under the topic's definition.95% confidence

Sub-Topics Women's Health

Track

in committee · Texas · House Aug 18, 2025

HB 82: Relating to abortion, including civil liability for distribution of abortion-inducing drugs; making conforming changes and harmonizing conforming provisions; authorizing a private civil right of action.

HB 82 prohibits the distribution of abortion-inducing drugs within Texas, targeting individuals or entities that manufacture, mail, transport, deliver, prescribe, or provide such drugs. It directly affects abortion providers, distributors, and those who facilitate access to these drugs, while excluding internet service providers, search engines, and cloud service providers from liability under the law. The bill creates a private civil right of action, allowing individuals to sue violators for damages related to the distribution of abortion-inducing drugs. These provisions are codified under the new "Women and Child Protection Act" in the Health and Safety Code.

Topics ✗ HealthcareOpposes HealthcareRestricts access to abortion drugs (a healthcare service) by prohibiting distribution and enabling civil lawsuits against providers, directly limiting patient access to medical care.95% confidence

Sub-Topics Women's Health

Track

in committee · Texas · House Aug 18, 2025

HB 80: Relating to abortion, including civil liability for distribution of abortion-inducing drugs and duties of Internet service providers; creating a criminal offense; authorizing a private civil right of action.

HB 80 imposes civil liability on individuals or entities distributing abortion-inducing drugs and requires internet service providers to take specific actions related to such content. The bill creates a new criminal offense for violations and authorizes private individuals to file civil lawsuits for breaches of the law. This legislation directly affects distributors of abortion drugs, internet service providers, and those involved in civil litigation under the new provisions. Note: Specific details of the internet service provider duties and criminal offense are not provided in the available bill text.

Topics ✗ Criminal JusticeOpposes Criminal JusticeCreates new criminal offense for abortion drug distribution, expanding criminalization within 'Crimes--Against Morals' subject category.95% confidence ✗ HealthcareOpposes HealthcareRestricts access to abortion drugs (a healthcare service) by imposing civil liability and criminal penalties on distributors, directly limiting a healthcare option.95% confidence

Sub-Topics Women's Health

Track

introduced · Texas · Senate Aug 18, 2025

SB 43: Relating to exceptions to and the repeal of certain laws prohibiting abortion.

Texas Senate Bill 43 creates a new exception to the state's abortion ban for pregnancies resulting from sexual assault (as defined under specific Penal Code sections), without requiring the patient to file a police report, provide forensic evidence, or pursue prosecution. It repeals Chapter 6-1/2 of the Texas Health and Safety Code, which was the primary statute prohibiting abortion, and clarifies that this exception does not repeal other abortion regulations or restrict local governments from imposing stricter abortion bans. The bill exempts abortions performed under this exception from certain reporting requirements under Sections 171.203 and 171.204. This directly affects pregnant patients who have experienced sexual assault and healthcare providers performing abortions under this specific exception.

Topics ✓ HealthcareSupports HealthcareCreates new abortion access exception for sexual assault victims, expanding healthcare access in reproductive services without requiring police reports or evidence.95% confidence

Sub-Topics Women's Health

Track

in committee · Texas · House Aug 20, 2025

HB 216: Relating to the provision of an abortion-inducing drug.

This bill requires physicians to be physically present in Texas during an in-person examination when providing abortion-inducing drugs to patients. It directly affects physicians who prescribe these drugs within Texas, prohibiting remote or telemedicine provision. The key mechanism mandates that a physician must be in the state and examine the patient at the time of drug administration, as specified in amended Health and Safety Code Section 171.063(b). Exceptions for out-of-state consultations (e.g., for non-abortion medical services) do not apply to abortion-inducing drugs, as clarified in amended Occupations Code Section 151.056(b-1).

Topics ✗ HealthcareOpposes HealthcareRestricts telemedicine access to abortion drugs, limiting patient access to reproductive healthcare services as mandated by amended Health and Safety Code.95% confidence

Sub-Topics Telehealth Women's Health

Track